
		From Wikipedia, the free encyclopedia
		
		
		
		
		Jump to navigation
		Jump to search
		An outcome measure, endpoint, effect measure or measure of effect is a measure within medical practice or research, (primarily clinical trials) which is used to assess the effect, both positive and negative, of an intervention or treatment.[1][2] Measures can often be quantified using effect sizes.[3] Outcomes measures can be patient-reported, or gathered through laboratory tests such as blood work, urine samples etc. or through medical examination.[1] Outcomes measures should be relevant to the target of the intervention (be it a single person or a target population).[2]
Depending on the design of a trial, outcome measures can be either primary outcomes, in which case the trial is designed around finding an adequate study size (through proper randomization and power calculation).[1] Secondary or tertiary outcomes are outcome measures which are added after the design of the study is finalized, for example when data has already been collected. A study can have multiple primary outcome measures.[1]
Outcome measures can be divided into clinical endpoints and surrogate endpoints where the former is directly related to what the goal of the intervention, and the latter are indirectly related.[1]

Relevance[edit]
Outcome measures used in trials should consider relevance to the target of the study. In clinical trials such measures of direct importance for an individual may be survival, quality of life, morbidity, suffering, functional impairment or changes in symptoms.[2]
Outcome measures can be divided into clinical endpoints which are directly relevant to the target and surrogate endpoints (also called "proxy measures"), which are indirectly related.[1] Death from cardiovascular disease is an example of a clinical endpoint, whereas measurements of blood pressure, which is not normally associated with any symptoms, is a surrogate endpoint. Other examples of surrogate endpoints are blood lipoproteins and bone density.[2]
Composite measures or combined measures are common in clinical research.[1][2] The rationale is that combining different outcome measures gives greater statistical power. For example, the composite measure Killed or Seriously Injured" is often used in studies of road safety. While deaths are easier to count and are an outcome of undisputed importance, they are also much fewer than the number seriously injured; many of the "seriously injured" will not have experienced a major life event. However, composite measures should be used with care, particularly when surrogate endpoints are included.[2] A statistically significant effect of a composite measure can often be explained solely by effects of a surrogate endpoint or a variable that is less relevant. It is also possible that composite measures may mask negative treatment effects of truly important outcomes, such as death or cardiovascular events.[2]

References[edit]

^ Jump up to: a b c d e f g .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}Ross, David A.; Morrow, Richard H.; Smith, Peter G. (2015). Outcome measures and case definition. Oxford University Press. doi:10.1093/med/9780198732860.003.0012. ISBN 9780191797675.

^ Jump up to: a b c d e f g Assessment of methods in health care - A handbook (PDF). www.sbu.se (Preliminarily translated version, April 2018 ed.). Swedish Agency for Health Technology Assessment and Assessment of Social Services. April 2018 [April 2018]. pp. 18–19. Retrieved 2019-08-28. Lay summary. {{cite book}}: Cite uses deprecated parameter |lay-url= (help)

^ Tripepi, G.; Jager, K.J.; Dekker, F.W.; Wanner, C.; Zoccali, C. (October 2007). "Measures of effect: Relative risks, odds ratios, risk difference, and 'number needed to treat'". Kidney International. 72 (7): 789–791. doi:10.1038/sj.ki.5002432. PMID 17653136.


.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vteClinical research and experimental designOverview
Clinical trial
Trial protocols
Adaptive clinical trial
Academic clinical trials
Clinical study design
Controlled study(EBM I to II-1)
Randomized controlled trial
Scientific experiment
Blind experiment
Open-label trial
Observational study(EBM II-2 to II-3)
Cross-sectional study vs. Longitudinal study, Ecological study
Cohort study
Retrospective
Prospective
Case–control study (Nested case–control study)
Case series
Case study
Case report
MeasuresOccurrenceIncidence, Cumulative incidence, Prevalence, Point prevalence, Period prevalenceAssociationRisk difference, Number needed to treat, Number needed to harm, Risk ratio, Relative risk reduction, Odds ratio, Hazard ratioPopulation impactAttributable fraction among the exposed, Attributable fraction for the population, Preventable fraction among the unexposed, Preventable fraction for the populationOtherClinical endpoint, Virulence, Infectivity, Mortality rate, Morbidity, Case fatality rate, Specificity and sensitivity, Likelihood-ratios, Pre- and post-test probabilityTrial/test types
In vitro
In vivo
Animal testing
Animal testing on non-human primates
First-in-man study
Multicenter trial
Seeding trial
Vaccine trial
Analysis of clinical trials
Risk–benefit ratio
Systematic review
Replication
Meta-analysis
Intention-to-treat analysis
Interpretation of results
Selection bias
Survivorship bias
Correlation does not imply causation
Null result
Sex as a biological variable

Category
Glossary
List of topics





<img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" />
Retrieved from "https://en.wikipedia.org/w/index.php?title=Outcome_measure&oldid=1032296135"
		Categories: Clinical medicineResearchHidden categories: CS1 errors: deprecated parameters
	